» Articles » PMID: 27901111

Optogenetic Clustering of CNK1 Reveals Mechanistic Insights in RAF and AKT Signalling Controlling Cell Fate Decisions

Overview
Journal Sci Rep
Specialty Science
Date 2016 Dec 1
PMID 27901111
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Scaffold proteins such as the multidomain protein CNK1 orchestrate the signalling network by integrating and controlling the underlying pathways. Using an optogenetic approach to stimulate CNK1 uncoupled from upstream effectors, we identified selective clusters of CNK1 that either stimulate RAF-MEK-ERK or AKT signalling depending on the light intensity applied. OptoCNK1 implemented in MCF7 cells induces differentiation at low light intensity stimulating ERK activity whereas stimulation of AKT signalling by higher light intensity promotes cell proliferation. CNK1 clustering in response to increasing EGF concentrations revealed that CNK1 binds to RAF correlating with ERK activation at low EGF dose. At higher EGF dose active AKT binds to CNK1 and phosphorylates and inhibits RAF. Knockdown of CNK1 protects CNK1 from this AKT/RAF crosstalk. In C2 skeletal muscle cells CNK1 expression is induced with the onset of differentiation. Hence, AKT-bound CNK1 counteracts ERK stimulation in differentiated but not in proliferating cells. Ectopically expressed CNK1 facilitates C2 cell differentiation and knockdown of CNK1 impaired the transcriptional network underlying C2 cell differentiation. Thus, CNK1 expression, CNK1 clustering and the thereto related differential signalling processes decide on proliferation and differentiation in a cell type- and cell stage-dependent manner by orchestrating AKT and RAF signalling.

Citing Articles

Cell Cycle Control by Optogenetically Regulated Cell Cycle Inhibitor Protein p21.

Lataster L, Huber H, Bottcher C, Foller S, Takors R, Radziwill G Biology (Basel). 2023; 12(9).

PMID: 37759593 PMC: 10525493. DOI: 10.3390/biology12091194.


Scaffolding Protein Connector Enhancer of Kinase Suppressor of Ras 1 (CNKSR1) Regulates MAPK Inhibition Responsiveness in Pancreas Cancer via Crosstalk with AKT Signaling.

Li D, Miermont A, Sable R, Quadri H, Mathews Griner L, Martin S Mol Cancer Res. 2023; 21(4):316-331.

PMID: 36790955 PMC: 10068447. DOI: 10.1158/1541-7786.MCR-21-1036.


Rapid and reversible optogenetic silencing of synaptic transmission by clustering of synaptic vesicles.

Vettkotter D, Schneider M, Goulden B, Dill H, Liewald J, Zeiler S Nat Commun. 2022; 13(1):7827.

PMID: 36535932 PMC: 9763335. DOI: 10.1038/s41467-022-35324-z.


Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer.

Zhang Y, Lin Y, Lv D, Wu X, Li W, Wang X PeerJ. 2022; 10:e12843.

PMID: 35127296 PMC: 8796709. DOI: 10.7717/peerj.12843.


External validation of integrated genetic-epigenetic biomarkers for predicting incident coronary heart disease.

Dogan M, Knight S, Dogan T, Knowlton K, Philibert R Epigenomics. 2021; 13(14):1095-1112.

PMID: 34148365 PMC: 8356680. DOI: 10.2217/epi-2021-0123.


References
1.
Claperon A, Therrien M . KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene. 2007; 26(22):3143-58. DOI: 10.1038/sj.onc.1210408. View

2.
Zhou J, Du T, Li B, Rong Y, Verkhratsky A, Peng L . Crosstalk Between MAPK/ERK and PI3K/AKT Signal Pathways During Brain Ischemia/Reperfusion. ASN Neuro. 2015; 7(5). PMC: 4601130. DOI: 10.1177/1759091415602463. View

3.
Alessi D, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P . Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996; 15(23):6541-51. PMC: 452479. View

4.
Baljuls A, Kholodenko B, Kolch W . It takes two to tango--signalling by dimeric Raf kinases. Mol Biosyst. 2012; 9(4):551-8. DOI: 10.1039/c2mb25393c. View

5.
Garcia R, Grindlay J, Rath O, Fee F, Kolch W . Regulation of human myoblast differentiation by PEBP4. EMBO Rep. 2009; 10(3):278-84. PMC: 2658556. DOI: 10.1038/embor.2009.4. View